UA83341C2 - Біополярні солі транс-каротиноїдів та їх використання - Google Patents
Біополярні солі транс-каротиноїдів та їх використання Download PDFInfo
- Publication number
- UA83341C2 UA83341C2 UA20040807055A UA20040807055A UA83341C2 UA 83341 C2 UA83341 C2 UA 83341C2 UA 20040807055 A UA20040807055 A UA 20040807055A UA 20040807055 A UA20040807055 A UA 20040807055A UA 83341 C2 UA83341 C2 UA 83341C2
- Authority
- UA
- Ukraine
- Prior art keywords
- aai
- eee
- aver
- miiiiza
- ibe
- Prior art date
Links
- 235000021466 carotenoid Nutrition 0.000 title abstract 2
- 150000001747 carotenoids Chemical class 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- SETMGIIITGNLAS-UHFFFAOYSA-N spizofurone Chemical compound O=C1C2=CC(C(=O)C)=CC=C2OC21CC2 SETMGIIITGNLAS-UHFFFAOYSA-N 0.000 claims description 17
- 229950001870 spizofurone Drugs 0.000 claims description 17
- 241000258740 Abia Species 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims 1
- 244000301682 Heliotropium curassavicum Species 0.000 claims 1
- 235000015854 Heliotropium curassavicum Nutrition 0.000 claims 1
- 244000088401 Pyrus pyrifolia Species 0.000 claims 1
- 235000001630 Pyrus pyrifolia var culta Nutrition 0.000 claims 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- -1 carotenoid salt compounds Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000003743 erythrocyte Anatomy 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
- 235000013929 Psidium pyriferum Nutrition 0.000 description 9
- 244000236580 Psidium pyriferum Species 0.000 description 9
- YLBMNMLHAAOXAL-UHFFFAOYSA-N aziv Chemical compound O1C(C)=C(O)C(=O)CC1OC1C2(C)CCC3(C)C4(C)CCC5C(C)(CO)C(OC6C(C(O)C(O)C(O6)C(O)=O)OC6C(C(O)C(O)C(CO)O6)OC6C(C(O)C(O)C(CO)O6)O)CCC5(C)C4CC=C3C2CC(C)(C)C1 YLBMNMLHAAOXAL-UHFFFAOYSA-N 0.000 description 6
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 description 2
- 241000223477 Abea Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000595072 Aidia Species 0.000 description 1
- 241000534414 Anotopterus nikparini Species 0.000 description 1
- 241000566146 Asio Species 0.000 description 1
- 241001057406 Azya Species 0.000 description 1
- 241001142392 Bibio Species 0.000 description 1
- 241000347889 Debia Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 241000408551 Meza Species 0.000 description 1
- 241001387976 Pera Species 0.000 description 1
- 241000435574 Popa Species 0.000 description 1
- 208000010094 Visna Diseases 0.000 description 1
- 241001621721 Ziba Species 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- DIRFUJHNVNOBMY-UHFFFAOYSA-N fenobucarb Chemical compound CCC(C)C1=CC=CC=C1OC(=O)NC DIRFUJHNVNOBMY-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
- C07C69/602—Dicarboxylic acid esters having at least two carbon-to-carbon double bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/06—Potassium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C305/00—Esters of sulfuric acids
- C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
- C07C305/14—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/04—Sodium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/113—Esters of phosphoric acids with unsaturated acyclic alcohols
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Toxicology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35871802P | 2002-02-25 | 2002-02-25 | |
| PCT/US2003/005521 WO2003072734A2 (en) | 2002-02-25 | 2003-02-25 | Bipolar trans carotenoid salts and their uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA83341C2 true UA83341C2 (uk) | 2008-07-10 |
Family
ID=27765977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA20040807055A UA83341C2 (uk) | 2002-02-25 | 2003-02-25 | Біополярні солі транс-каротиноїдів та їх використання |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US7351844B2 (https=) |
| EP (1) | EP1487774B1 (https=) |
| JP (4) | JP2005518453A (https=) |
| KR (1) | KR101020115B1 (https=) |
| CN (1) | CN1671643B (https=) |
| AU (1) | AU2003215396B2 (https=) |
| BR (1) | BR0307935A (https=) |
| CA (1) | CA2477245A1 (https=) |
| CZ (1) | CZ2004904A3 (https=) |
| EA (1) | EA200401111A1 (https=) |
| HU (1) | HUP0500134A3 (https=) |
| IL (1) | IL163685A0 (https=) |
| MX (1) | MXPA04008253A (https=) |
| NO (1) | NO20043661L (https=) |
| NZ (2) | NZ564486A (https=) |
| PL (1) | PL373780A1 (https=) |
| UA (1) | UA83341C2 (https=) |
| WO (1) | WO2003072734A2 (https=) |
| ZA (1) | ZA200406673B (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| CA2477245A1 (en) * | 2002-02-25 | 2003-09-04 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| AU2011265546B2 (en) * | 2003-08-25 | 2016-05-12 | Diffusion Pharmaceuticals Llc | Bipolar Trans Carotenoid Salts and Their Uses |
| CA2537210C (en) * | 2003-08-25 | 2013-06-04 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| EP2540696B1 (en) * | 2005-02-24 | 2020-01-01 | Diffusion Pharmaceuticals LLC | Trans carotenoids, formulation and uses |
| JPWO2006112283A1 (ja) * | 2005-04-13 | 2008-12-11 | 理研ビタミン株式会社 | 抗疲労剤 |
| EP1965807A4 (en) * | 2005-11-23 | 2010-10-27 | Epix Delaware Inc | S1P RECEPTOR MODULATING COMPOUNDS AND THEIR USE |
| US20070288322A1 (en) * | 2006-05-23 | 2007-12-13 | Toshiba Tec Kabushiki Kaisha | Portable terminal and its programs, settlement apparatus, and merchandising information providing apparatus |
| CN101687757A (zh) | 2007-04-13 | 2010-03-31 | 扩散药品有限公司 | 双极性反式类胡萝卜素作为预治疗及其在周围血管疾病的治疗中的应用 |
| CA2688837A1 (en) * | 2007-06-19 | 2008-12-24 | Novartis Ag | Organic compounds |
| KR20100083820A (ko) | 2007-10-31 | 2010-07-22 | 디퓨젼 파마슈티컬즈 엘엘씨 | 저분자 확산을 촉진시키는 신규한 치료요법 |
| CN101157645B (zh) * | 2007-11-27 | 2010-06-02 | 江南大学 | 一种藏红花酸的合成方法 |
| EP2445339B1 (en) | 2009-06-22 | 2019-08-07 | Diffusion Pharmaceuticals LLC | Diffusion enhancing compound and its use with a thrombolytic |
| JP2010090151A (ja) * | 2009-12-09 | 2010-04-22 | Diffusion Pharmaceuticals Llc | 双極性トランスカロテノイド塩及びそれらの使用 |
| AU2011262361A1 (en) | 2010-06-02 | 2013-01-10 | Diffusion Pharmaceuticals Llc | Oral formulations of bipolar trans carotenoids |
| CN101967087A (zh) * | 2010-09-21 | 2011-02-09 | 上海大学 | (e)- 4.4-二甲氧基-2-丁烯醛的制备方法 |
| CN103172504B (zh) * | 2011-12-26 | 2014-10-08 | 南京工业大学 | 2,7-二甲基-2,4,6-辛三烯-1,8-二醛的合成方法 |
| CA3018550A1 (en) | 2016-03-24 | 2017-09-28 | Diffusion Pharmaceuticals Llc | Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer |
| JP7355394B2 (ja) | 2018-05-03 | 2023-10-03 | エル．イー．エー．エフ． ホールディングス グループ エルエルシー | カロテノイド組成物およびその使用 |
| WO2021207690A1 (en) * | 2020-04-09 | 2021-10-14 | L.E.A.F. Holdings Group Llc | Trans-crocetin compositions and treatment regimens |
| WO2021207650A1 (en) * | 2020-04-09 | 2021-10-14 | L.E.A.F. Holdings Group Llc | Trans-crocetin compositions and treatment regimens |
| US20240316000A1 (en) * | 2021-06-29 | 2024-09-26 | Diffusion Pharmaceuticals Llc | Methods of treatment |
| WO2023081779A1 (en) * | 2021-11-03 | 2023-05-11 | Diffusion Pharmaceuticals Llc | Crystalline forms of a diffusion enhancing compound |
| CN114534729B (zh) * | 2022-03-07 | 2024-05-03 | 万华化学集团股份有限公司 | 一种催化剂及其制备方法和其在电化学法制备β-胡萝卜素中的应用 |
Family Cites Families (71)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2948748A (en) * | 1960-08-09 | Esters thereof | ||
| US2175843A (en) * | 1936-06-26 | 1939-10-10 | Winthrop Chem Co Inc | Polyene carboxylic acids and esters and manufacture thereof |
| CH468330A (de) | 1966-01-28 | 1969-02-15 | Hoffmann La Roche | Verfahren zur Herstellung von isoprenoiden Verbindungen |
| US3489806A (en) | 1967-01-19 | 1970-01-13 | Hoffmann La Roche | Isoprenoid compounds and a process for producing the same |
| CH522572A (de) | 1969-10-31 | 1972-06-30 | Hoffmann La Roche | Verfahren zur Herstellung von Polyenverbindungen |
| US3788468A (en) * | 1973-05-01 | 1974-01-29 | Univ Virginia | Process for increasing oxygen diffusivity |
| US3853993A (en) * | 1973-05-01 | 1974-12-10 | Univ Virginia | Process for increasing oxygen diffusivity and method for treating atherosclerosis |
| US3853933A (en) * | 1974-01-14 | 1974-12-10 | Gen Electric | Continuous process for producing polysiloxane oils utilizing a carbon black catalyst |
| DE2505869C3 (de) * | 1975-02-12 | 1978-05-18 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von symmetrischen Carotinoiden |
| US3965261A (en) * | 1975-04-29 | 1976-06-22 | University Of Virginia | Method for treating papillomas |
| US3975519A (en) * | 1975-06-09 | 1976-08-17 | University Of Virginia | Method for increasing the oxygen partial pressure in the bloodstream of mammals |
| US4070460A (en) * | 1975-11-10 | 1978-01-24 | University Of Virginia Patents Foundation | Method for treating cerebral edema |
| US4009270A (en) * | 1975-11-21 | 1977-02-22 | The University Of Virginia | Method for treating spinal cord injury |
| US4038144A (en) * | 1976-04-19 | 1977-07-26 | The University Of Virginia | Method of increasing fermentation yields |
| US4046880A (en) * | 1976-04-20 | 1977-09-06 | The University Of Virginia | Method of treating hypertension |
| US4068144A (en) * | 1976-09-20 | 1978-01-10 | Recognition Equipment Incorporated | Liquid jet modulator with piezoelectric hemispheral transducer |
| US4099270A (en) * | 1977-02-16 | 1978-07-11 | Jabour Richard J | Slip-on rubber gloves |
| US4216211A (en) * | 1977-10-31 | 1980-08-05 | The Procter & Gamble Company | Therapeutic composition |
| US4176179A (en) * | 1978-04-17 | 1979-11-27 | The University Of Virginia Alumni Patents Foundation | Method for treating arthritis |
| US4699664A (en) | 1985-05-01 | 1987-10-13 | Nestec S.A. | Stabilized natural pigment complexes |
| US5032613A (en) * | 1986-02-12 | 1991-07-16 | W. Keith R. Watson | Method and composition for treating arthritis |
| JPH0661211B2 (ja) * | 1986-08-29 | 1994-08-17 | 花王株式会社 | パン用改質剤、パン生地及びパンの製造方法 |
| US5811119A (en) | 1987-05-19 | 1998-09-22 | Board Of Regents, The University Of Texas | Formulation and use of carotenoids in treatment of cancer |
| US5472946A (en) | 1988-04-08 | 1995-12-05 | Peck; James V. | Transdermal penetration enhancers |
| FR2647343B1 (fr) | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
| IT1233303B (it) | 1989-06-07 | 1992-03-26 | Azionaria Costruzioni Acma Spa | Apparecchiatura per il convogliamento di prodotti |
| US5053240A (en) | 1989-10-24 | 1991-10-01 | Kalamazoo Holdings, Inc. | Norbixin adducts with water-soluble or water-dispersible proteins or branched-chain or cyclic polysaccharides |
| US5175843A (en) * | 1989-10-30 | 1992-12-29 | General Electric Company | Computer-aided design method for restructuring computational networks to minimize shimming delays |
| JPH04264020A (ja) | 1991-02-18 | 1992-09-18 | Yamanouchi Pharmaceut Co Ltd | 安定な凍結乾燥製剤 |
| US5107030A (en) * | 1991-03-04 | 1992-04-21 | Loyola University Of Chicago | Method of making 2,7-dimethyl-2,4,6-octatrienedial and derivatives thereof |
| JP3176716B2 (ja) | 1991-06-21 | 2001-06-18 | 武田薬品工業株式会社 | 溶解性が向上した難水溶性薬物組成物 |
| JP2977961B2 (ja) * | 1991-07-26 | 1999-11-15 | 株式会社資生堂 | 化粧料 |
| JPH06248193A (ja) | 1993-02-25 | 1994-09-06 | Ensuiko Sugar Refining Co Ltd | クロセチン含有着色料 |
| IL110139A0 (en) * | 1993-06-28 | 1994-10-07 | Howard Foundation | Pharmaceutically-active antioxidants |
| JPH0723736A (ja) | 1993-06-30 | 1995-01-27 | Taishiyoo Technos:Kk | カロチノイド色素の可溶化方法 |
| JP2704356B2 (ja) | 1994-02-08 | 1998-01-26 | 正和薬品株式会社 | 脳機能改善剤 |
| JPH07291854A (ja) | 1994-04-26 | 1995-11-07 | Tanabe Seiyaku Co Ltd | 溶解性の改善された医薬品製剤 |
| GB2290964A (en) | 1994-07-08 | 1996-01-17 | Arto Olavi Urtti | Transdermal drug delivery system |
| US6060511A (en) * | 1995-10-05 | 2000-05-09 | Gainer; John L. | Trans-sodium crocetinate, methods of making and methods of use thereof |
| US6090771A (en) * | 1996-10-24 | 2000-07-18 | Reckitt Benckiser Inc. | Low residue aqueous hard surface cleaning and disinfecting compositions |
| RU2107496C1 (ru) | 1997-02-10 | 1998-03-27 | Российская медицинская академия последипломного образования Министерства здравоохранения РФ | Способ лечения диабетической ангиопатии |
| US6391336B1 (en) | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| US6150561A (en) * | 1997-10-03 | 2000-11-21 | Roche Vitamins Inc. | Method of making carotenoids |
| JPH11209642A (ja) | 1998-01-27 | 1999-08-03 | Taito Kk | アナトー色素製剤及びその製造方法 |
| MA25590A1 (fr) | 1998-09-14 | 2002-12-31 | Inhale Therapeutic Syst | Agent actif de delivraison de poudre seche |
| BE1012495A3 (fr) * | 1999-03-02 | 2000-11-07 | Messadek Jallal | La glycine-betaine pour son usage antithrombotique. |
| CA2355814C (en) | 2000-09-14 | 2010-06-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Pharmaceutical composition for ophthalmic use |
| CA2477245A1 (en) | 2002-02-25 | 2003-09-04 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| US7759506B2 (en) | 2002-02-25 | 2010-07-20 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| US20030180282A1 (en) | 2002-03-25 | 2003-09-25 | Victor Serebruany | Method of treatment of thrombotic events |
| RU2226096C1 (ru) | 2002-07-01 | 2004-03-27 | Санкт-Петербургский государственный научно-исследовательский институт скорой помощи им. И.И.Джанелидзе | Способ лечения последствий тканевой гипоксии у пациентов в критическом состоянии |
| CN101845009B (zh) * | 2002-07-29 | 2012-10-03 | 卡达克斯药物公司 | 用于抑制和改善疾病的类胡萝卜素结构类似物 |
| DE10254809A1 (de) | 2002-11-22 | 2004-06-03 | Basf Ag | Verfahren zur Herstellung von Carotinoiden |
| EP1569692B1 (en) | 2002-11-25 | 2010-11-10 | Jallal Messadek | Betaine and salicylic acid compositions |
| US20040109920A1 (en) | 2002-12-04 | 2004-06-10 | Bioactives Llc | Coated carotenoid cyclodextrin complexes |
| CA2537210C (en) | 2003-08-25 | 2013-06-04 | Diffusion Pharmaceuticals Llc | Bipolar trans carotenoid salts and their uses |
| RU2265434C2 (ru) | 2003-09-30 | 2005-12-10 | Государственное учреждение Научно-исследовательский Институт Общей реаниматологии Российской Академии Медицинских Наук (ГУ НИИ ОР РАМН) | Способ лечения острого респираторного дистресс-синдрома |
| RU2256446C1 (ru) | 2003-10-22 | 2005-07-20 | Государственное учреждение Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова | Способ профилактики метастазов после хирургического удаления внутриглазных новообразований |
| US7446101B1 (en) | 2003-12-12 | 2008-11-04 | Bioactives, Llc | Bioavailable carotenoid-cyclodextrin formulations for soft-gels and other encapsulation systems |
| WO2005120495A1 (en) | 2004-06-14 | 2005-12-22 | Salama Zoser B | Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody |
| JP4514114B2 (ja) | 2004-06-18 | 2010-07-28 | ヤマハ発動機株式会社 | コイル可動形リニアモータおよび単軸ロボット |
| EP1802287A2 (en) | 2004-09-27 | 2007-07-04 | Sigmoid Biotechnologies Limited | Minicapsule formulations |
| WO2006039685A2 (en) | 2004-10-01 | 2006-04-13 | Hawaii Biotech, Inc. | Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives |
| EP2540696B1 (en) | 2005-02-24 | 2020-01-01 | Diffusion Pharmaceuticals LLC | Trans carotenoids, formulation and uses |
| US20090176287A1 (en) | 2005-02-24 | 2009-07-09 | Regents Of The University Of Minnesota | Producing carotenoids |
| WO2006099015A2 (en) | 2005-03-09 | 2006-09-21 | Cardax Pharmaceuticals, Inc. | Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders |
| EP2258441A3 (en) | 2005-09-02 | 2011-09-21 | Intercell USA, Inc. | Devices for transcutaneous delivery of vaccines and transdermal delivery of drugs |
| ITMI20052486A1 (it) | 2005-12-23 | 2007-06-24 | Italiana Sint Spa | Procedimento di sintesi di intermedi per la preparazione di astaxantina |
| CA2644423A1 (en) | 2006-03-24 | 2007-10-04 | Ian Simon Tracton | Stable packaged dosage form and process therefor |
| CN101687757A (zh) | 2007-04-13 | 2010-03-31 | 扩散药品有限公司 | 双极性反式类胡萝卜素作为预治疗及其在周围血管疾病的治疗中的应用 |
| KR20100083820A (ko) | 2007-10-31 | 2010-07-22 | 디퓨젼 파마슈티컬즈 엘엘씨 | 저분자 확산을 촉진시키는 신규한 치료요법 |
-
2003
- 2003-02-25 CA CA002477245A patent/CA2477245A1/en not_active Abandoned
- 2003-02-25 EA EA200401111A patent/EA200401111A1/ru unknown
- 2003-02-25 HU HU0500134A patent/HUP0500134A3/hu unknown
- 2003-02-25 BR BR0307935-0A patent/BR0307935A/pt not_active IP Right Cessation
- 2003-02-25 NZ NZ564486A patent/NZ564486A/en not_active IP Right Cessation
- 2003-02-25 KR KR1020047013118A patent/KR101020115B1/ko not_active Expired - Fee Related
- 2003-02-25 AU AU2003215396A patent/AU2003215396B2/en not_active Ceased
- 2003-02-25 NZ NZ535323A patent/NZ535323A/en not_active IP Right Cessation
- 2003-02-25 UA UA20040807055A patent/UA83341C2/uk unknown
- 2003-02-25 JP JP2003571422A patent/JP2005518453A/ja not_active Withdrawn
- 2003-02-25 PL PL03373780A patent/PL373780A1/xx not_active Application Discontinuation
- 2003-02-25 CN CN038045664A patent/CN1671643B/zh not_active Expired - Fee Related
- 2003-02-25 WO PCT/US2003/005521 patent/WO2003072734A2/en not_active Ceased
- 2003-02-25 EP EP03711221.6A patent/EP1487774B1/en not_active Expired - Lifetime
- 2003-02-25 CZ CZ2004904A patent/CZ2004904A3/cs unknown
- 2003-02-25 US US10/372,717 patent/US7351844B2/en not_active Expired - Lifetime
- 2003-02-25 MX MXPA04008253A patent/MXPA04008253A/es active IP Right Grant
- 2003-02-25 IL IL16368503A patent/IL163685A0/xx unknown
-
2004
- 2004-08-23 ZA ZA200406673A patent/ZA200406673B/en unknown
- 2004-09-01 NO NO20043661A patent/NO20043661L/no not_active Application Discontinuation
-
2007
- 2007-03-19 US US11/723,383 patent/US20070161610A1/en not_active Abandoned
- 2007-04-27 US US11/790,779 patent/US8269027B2/en not_active Expired - Fee Related
-
2009
- 2009-12-02 JP JP2009274988A patent/JP2010106029A/ja active Pending
-
2010
- 2010-05-12 JP JP2010110185A patent/JP2010229137A/ja not_active Withdrawn
-
2012
- 2012-09-17 US US13/621,650 patent/US20140051759A1/en not_active Abandoned
-
2013
- 2013-09-24 JP JP2013197629A patent/JP5774655B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA83341C2 (uk) | Біополярні солі транс-каротиноїдів та їх використання | |
| COULSON | Egg size and shape in the Kittiwake (Rissa tridactyla) and their use in estimating age composition of populations | |
| Plesofsky-Vig et al. | Heat shock response of Neurospora crassa: protein synthesis and induced thermotolerance | |
| BLOMLÖF et al. | Viability of human periodontal ligament cells after storage in milk or saliva | |
| UA83416C2 (en) | Fused ring 4-oxopyrimidine derivative | |
| Pae Jr | Ventricular assist devices and total artificial hearts: a combined registry experience | |
| Balasundaram et al. | Oxygen toxicity in a polyamine-depleted spe2 delta mutant of Saccharomyces cerevisiae. | |
| Mustard | Platelet survival | |
| Doersen et al. | Cytoplasmic inheritance of erythromycin resistance in human cells. | |
| Elgavish et al. | Altered sulfate transport via anion exchange in CFPAC is corrected by retrovirus-mediated CFTR gene transfer | |
| Timmermans et al. | Biofilm formation on the Provox ActiValve: composition and ingrowth analyzed by Illumina paired‐end RNA sequencing, fluorescence in situ hybridization, and confocal laser scanning microscopy | |
| Fong et al. | Substrate-dependent adaptive regulation and trans-inhibition of System A-mediated amino acid transport. Studies using rat hepatoma plasma membrane vesicles | |
| Goldfine et al. | Effects of inhibitors of lipid synthesis on the replication of Rous sarcoma virus. A specific effect of cerulenin on the processing of major non-glycosylated viral structural proteins | |
| Korun et al. | Midline one-stage complete unifocalization early outcomes from a single center | |
| Sinclair | Discussion Methods and Criteria of Mammalian Cell Synchrony | |
| Uzochukwu et al. | Innovation strategy and sustainability of micro, small and medium enterprises in Southeast Nigeria | |
| Wojtyk et al. | Clonal selection in cultured human fibroblasts: role of protein synthetic errors. | |
| Masinading et al. | Forecasting the Semestral Enrollment of DOrSU Curricular Programs | |
| Sakamoto et al. | A Preliminary Study on Reaching Position Estimation Model for the Subtle Action Disruption | |
| Cruz | Educadores latinoamericanos y del Caribe del siglo XX al XXI | |
| Raxmonjon o’g’li | XX ASR 60-80-YILLARIDA FARG’ONA VODIYSI QISHLOQLARIDA MADANIY MUASSASALAR FAOLIYATI HAMDA AHOLINING DAM OLISH MASKANLARI ANDIJON VILOYATI MISOLIDA | |
| McConnell et al. | Will the true originator of the storm glass please own up | |
| Pavlenko et al. | Cercetarea manifestării competențelor sociale și emoționale la studenți | |
| Uways et al. | Reference List to the Poets andTheir Poems | |
| Radman et al. | Influence of Mn2+ ion binding on structural changes in metalloregulatory proteins SloR (S. mutans) and ScaR (S. gordonii) |